Marco Morosin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marco Morosin has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Giuseppe Gatti
Division of Cardiac Surgery, Cardio-thoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, 34149 Trieste, Italy
2 shared publications Ulrich Rosendahl
Royal Brompton Hospital, London, United Kingdom
2 shared publications- Alessandro Sionis
Cardiology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) , 28029 Madrid
1 shared publication Alessia Azzu
Adult Intensive Care Unit, Royal Brompton Hospital, London, United Kingdom
1 shared publication- Alessia Azzu
Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom
1 shared publication - Alex Rosenberg
Department of Anaesthesia and Critical Care, Harefield Hospital Part of Guys and St. Thomas’s NHS Foundation Trust London , London
1 shared publication
Latest Publications
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
Early ambulatory re-evaluation and follow-up of patients admitted in the acute cardiac care unit - Practical aspects on ambulatory follow-up of acute care patients: acute coronary syndromes, heart failure, ventricular arrhythmias, atrial arrhythmias, conductance disorders, myocarditis, pericarditis, other acute cardiac settings A Clinical Consensus Statement of the Association for Acute CardioVascular Care of the ESC
Early, structured ambulatory follow-up after hospitalization for acute cardiac events remains a key unmet need in cardiovascular care. This clinical consensus statement of the Association for Acute CardioVascular Care of the ESC provides pragmatic, condition-specific guidance on post discharge management and (early) ambulatory re-evaluation for patients admitted to an acute cardiac care unit. It complements existing disease-oriented guidelines by focusing on the vulnerable transition from hospital to home rather than on acute in-hospital treatment. The document first defines key concepts and outlines general principles regarding timing, content, and organization of the first post-discharge contacts, including risk stratification, medication reconciliation, symptom assessment, evaluation of psychosocial status and comorbidities, patient and family education, and integration of cardiac rehabilitation. In practice, the consensus statement discusses the patient’s path after discharge: how should the follow-up team look like, when should the first and subsequent visits be planned, what should be done at each contact, and how can multidisciplinary teams and hybrid (in-person plus remote) models be implemented according to local resources. Supplementary material highlights major evidence gaps, including the optimal timing and intensity of follow-up, the composition of ambulatory teams, the role of telemonitoring and digital health, and the needs of vulnerable populations. Overall, this consensus aims to support clinicians in designing structured, individualized, and scalable ambulatory pathways after acute cardiac care.
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
Early ambulatory re-evaluation and follow-up of patients admitted in the acute cardiac care unit - Practical aspects on ambulatory follow-up of acute care patients: acute coronary syndromes, heart failure, ventricular arrhythmias, atrial arrhythmias, conductance disorders, myocarditis, pericarditis, other acute cardiac settings A Clinical Consensus Statement of the Association for Acute CardioVascular Care of the ESC
Early, structured ambulatory follow-up after hospitalization for acute cardiac events remains a key unmet need in cardiovascular care. This clinical consensus statement of the Association for Acute CardioVascular Care of the ESC provides pragmatic, condition-specific guidance on post discharge management and (early) ambulatory re-evaluation for patients admitted to an acute cardiac care unit. It complements existing disease-oriented guidelines by focusing on the vulnerable transition from hospital to home rather than on acute in-hospital treatment. The document first defines key concepts and outlines general principles regarding timing, content, and organization of the first post-discharge contacts, including risk stratification, medication reconciliation, symptom assessment, evaluation of psychosocial status and comorbidities, patient and family education, and integration of cardiac rehabilitation. In practice, the consensus statement discusses the patient’s path after discharge: how should the follow-up team look like, when should the first and subsequent visits be planned, what should be done at each contact, and how can multidisciplinary teams and hybrid (in-person plus remote) models be implemented according to local resources. Supplementary material highlights major evidence gaps, including the optimal timing and intensity of follow-up, the composition of ambulatory teams, the role of telemonitoring and digital health, and the needs of vulnerable populations. Overall, this consensus aims to support clinicians in designing structured, individualized, and scalable ambulatory pathways after acute cardiac care.
- Open Access
- 20 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (8) , 851
Advanced Respiratory Failure Requiring Tracheostomy—A Marker of Unfavourable Prognosis after Heart Transplantation
Advanced respiratory failure with tracheostomy requirement is common in heart recipients. The aim of the study is to assess the tracheostomy rate after orthotopic heart transplantation and identify the subgroups of patients with the highest need for tracheostomy and these groups’ association with mortality at a single centre through a retrospective analysis of 140 consecutive patients transplanted between December 2012 and July 2018. As many as 28.6% heart recipients suffered from advanced respiratory failure with a need for tracheostomy that was performed after a median time of 11.5 days post-transplant. Tracheostomy was associated with a history of stroke (OR 3.4; 95% CI) 1.32–8.86; p = 0.012), previous sternotomy (OR 2.5; 95% CI 1.18–5.32; p = 0.017), longer cardiopulmonary bypass time (OR 1.01; 95% CI 1.00–1.01; p = 0.007) as well as primary graft failure (OR 6.79; 95% CI2.93–15.71; p < 0.001), need of renal replacement therapy (OR 19.2; 95% 2.53–146; p = 0.004) and daily mean SOFA score up to 72 h (OR 1.50; 95% 1.23–1.71; p < 0.01). One-year mortality was significantly higher in patients requiring a tracheostomy vs. those not requiring one during their hospital stay (50% vs. 16%, p < 0.001). The need for tracheostomy in heart transplant recipients was 30% in our study. Advanced respiratory failure was associated with over 3-fold greater 1-year mortality. Thus, tracheostomy placement may be regarded as a marker of unfavourable prognosis.
- 20 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (8) , 851
Open AccessAdvanced Respiratory Failure Requiring Tracheostomy—A Marker of Unfavourable Prognosis after Heart Transplantation
Advanced respiratory failure with tracheostomy requirement is common in heart recipients. The aim of the study is to assess the tracheostomy rate after orthotopic heart transplantation and identify the subgroups of patients with the highest need for tracheostomy and these groups’ association with mortality at a single centre through a retrospective analysis of 140 consecutive patients transplanted between December 2012 and July 2018. As many as 28.6% heart recipients suffered from advanced respiratory failure with a need for tracheostomy that was performed after a median time of 11.5 days post-transplant. Tracheostomy was associated with a history of stroke (OR 3.4; 95% CI) 1.32–8.86; p = 0.012), previous sternotomy (OR 2.5; 95% CI 1.18–5.32; p = 0.017), longer cardiopulmonary bypass time (OR 1.01; 95% CI 1.00–1.01; p = 0.007) as well as primary graft failure (OR 6.79; 95% CI2.93–15.71; p < 0.001), need of renal replacement therapy (OR 19.2; 95% 2.53–146; p = 0.004) and daily mean SOFA score up to 72 h (OR 1.50; 95% 1.23–1.71; p < 0.01). One-year mortality was significantly higher in patients requiring a tracheostomy vs. those not requiring one during their hospital stay (50% vs. 16%, p < 0.001). The need for tracheostomy in heart transplant recipients was 30% in our study. Advanced respiratory failure was associated with over 3-fold greater 1-year mortality. Thus, tracheostomy placement may be regarded as a marker of unfavourable prognosis.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Cardiovascular Imaging
- Vol. 29 (4) , 361-372
Cardiac Decompression by Pericardiectomy for Constrictive Pericarditis: Multimodality Imaging to Identify Patients at Risk for Prolonged Inotropic Support
Azzu A, et al. J Cardiovasc Imaging. 2021 May;29:e50. https://doi.org/10.4250/jcvi.2020.0223
- 1 January 2021
- Published by XMLink in Journal of Cardiovascular Imaging
- Vol. 29 (4) , 361-372
Open AccessCardiac Decompression by Pericardiectomy for Constrictive Pericarditis: Multimodality Imaging to Identify Patients at Risk for Prolonged Inotropic Support
Azzu A, et al. J Cardiovasc Imaging. 2021 May;29:e50. https://doi.org/10.4250/jcvi.2020.0223
- 27 July 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (10) , 2806-2807
Supravalvular mitral remnant: The other side of the… valve
We report a challenging clinical case of an atypical supravalvular mitral remnant in recent mitral and aortic valve replacement with mechanical valve prostheses, associated with postoperative recurrent inflammatory episodes overlapped with difficult anticoagulation. Negative myocardial scintigraphy was associated with persistence of negative blood cultures. Serial echocardiographic evaluation was performed before and after antimicrobial treatment, and at 3 months follow‐up a transesophageal echocardiography showed the persistence of the mass. Diagnostic suspect was finally confirmed.
- 27 July 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (10) , 2806-2807
Supravalvular mitral remnant: The other side of the… valve
We report a challenging clinical case of an atypical supravalvular mitral remnant in recent mitral and aortic valve replacement with mechanical valve prostheses, associated with postoperative recurrent inflammatory episodes overlapped with difficult anticoagulation. Negative myocardial scintigraphy was associated with persistence of negative blood cultures. Serial echocardiographic evaluation was performed before and after antimicrobial treatment, and at 3 months follow‐up a transesophageal echocardiography showed the persistence of the mass. Diagnostic suspect was finally confirmed.
- 26 July 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (9) , 858-859
Extensive cardiac infiltrative melanoma
We report an unusual clinical case of a 66-year-old patient with cardiac involvement from a metastatic melanoma, causing the formation of a large right atrial mass with extensive infiltration of the right atrial free wall, the interatrial septum, the coronary sinus, and up to the mitral annulus and posterior wall of the right ventricle, unamendable to complete surgical excision. As secondary cardiac tumors are not part of routine daily clinical practice, we thought that this clinical case would be a good educational opportunity for the practicing clinicians, both specialists and nonspecialists.
- 26 July 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (9) , 858-859
Extensive cardiac infiltrative melanoma
We report an unusual clinical case of a 66-year-old patient with cardiac involvement from a metastatic melanoma, causing the formation of a large right atrial mass with extensive infiltration of the right atrial free wall, the interatrial septum, the coronary sinus, and up to the mitral annulus and posterior wall of the right ventricle, unamendable to complete surgical excision. As secondary cardiac tumors are not part of routine daily clinical practice, we thought that this clinical case would be a good educational opportunity for the practicing clinicians, both specialists and nonspecialists.
- 11 August 2017
- Published by Springer Nature in Heart and Vessels
- Vol. 33 (2) , 113-125
Double versus single source left-sided coronary revascularization using bilateral internal thoracic artery graft alone
Left-sided coronary revascularization with bilateral internal thoracic artery (BITA) graft is performed usually either with an in situ (double source) or Y-graft configuration (single source). Two hundred fifty-three (mean age, 67.1 ± 9.5 years) patients underwent isolated left-sided coronary revascularization with BITA graft alone at the present authors’ institution (2000–2015). Skeletonized BITA grafts were used either in an in situ (n = 199) or Y-graft configuration (n = 54). Forty pairs were identified with the propensity score-matching. Outcomes of the two groups were compared both in unmatched and matched series. Cardiopulmonary exercise testing was performed in five pairs of selected, asymptomatic matched patients having patent BITA grafts at coronary computed tomography angiography. BITA in situ patients had lower risk profiles than BITA Y-graft patients (median EuroSCORE II, 1.9 vs. 2.9%, p = 0.051). In-hospital mortality (5.6 vs. 0, p = 0.0093) and the rates of postoperative complications except deep sternal wound infection were higher in BITA Y-graft patients. However, these differences were not confirmed in matched groups. During the follow-up period (mean, 5.9 ± 4.3 years), between BITA in situ and BITA Y-graft matched patients, there were no differences in non-parametric estimates of freedom from cardiac death (p = 0.6), major adverse cardiac and cerebrovascular events (MACCEs, p = 0.65), and repeat coronary revascularization (p = 0.44). Adjusted risk estimates of MACCEs according to BITA configuration confirmed no superiority of the one configuration over the other (p ≥ 0.44). No significant differences were found at the cardiopulmonary exercise testing. Results of left-sided coronary revascularization with BITA graft alone are independent from BITA configuration, even after stress testing.
- 11 August 2017
- Published by Springer Nature in Heart and Vessels
- Vol. 33 (2) , 113-125
Double versus single source left-sided coronary revascularization using bilateral internal thoracic artery graft alone
Left-sided coronary revascularization with bilateral internal thoracic artery (BITA) graft is performed usually either with an in situ (double source) or Y-graft configuration (single source). Two hundred fifty-three (mean age, 67.1 ± 9.5 years) patients underwent isolated left-sided coronary revascularization with BITA graft alone at the present authors’ institution (2000–2015). Skeletonized BITA grafts were used either in an in situ (n = 199) or Y-graft configuration (n = 54). Forty pairs were identified with the propensity score-matching. Outcomes of the two groups were compared both in unmatched and matched series. Cardiopulmonary exercise testing was performed in five pairs of selected, asymptomatic matched patients having patent BITA grafts at coronary computed tomography angiography. BITA in situ patients had lower risk profiles than BITA Y-graft patients (median EuroSCORE II, 1.9 vs. 2.9%, p = 0.051). In-hospital mortality (5.6 vs. 0, p = 0.0093) and the rates of postoperative complications except deep sternal wound infection were higher in BITA Y-graft patients. However, these differences were not confirmed in matched groups. During the follow-up period (mean, 5.9 ± 4.3 years), between BITA in situ and BITA Y-graft matched patients, there were no differences in non-parametric estimates of freedom from cardiac death (p = 0.6), major adverse cardiac and cerebrovascular events (MACCEs, p = 0.65), and repeat coronary revascularization (p = 0.44). Adjusted risk estimates of MACCEs according to BITA configuration confirmed no superiority of the one configuration over the other (p ≥ 0.44). No significant differences were found at the cardiopulmonary exercise testing. Results of left-sided coronary revascularization with BITA graft alone are independent from BITA configuration, even after stress testing.
- Open Access
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 3 (3) , 686-688
An unusual etiology of torsade de pointes-induced syncope
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 3 (3) , 686-688
Open AccessAn unusual etiology of torsade de pointes-induced syncope